Page last updated: 2024-09-04

lubiprostone and cdaa

lubiprostone has been researched along with cdaa in 1 studies

Compound Research Comparison

Studies
(lubiprostone)
Trials
(lubiprostone)
Recent Studies (post-2010)
(lubiprostone)
Studies
(cdaa)
Trials
(cdaa)
Recent Studies (post-2010) (cdaa)
2143813430125

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Akahane, T; Enomoto, M; Fujimoto, Y; Fujinaga, Y; Kaji, K; Kawaratani, H; Murata, K; Namisaki, T; Nishimura, N; Takaya, H; Takeda, S; Tsuji, Y; Yoshiji, H1

Other Studies

1 other study(ies) available for lubiprostone and cdaa

ArticleYear
Rifaximin and lubiprostone mitigate liver fibrosis development by repairing gut barrier function in diet-induced rat steatohepatitis.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2022, Volume: 54, Issue:10

    Topics: Acetamides; Amino Acids; Animals; Caco-2 Cells; Chloride Channels; Choline; Diet; Humans; Lipopolysaccharides; Liver; Liver Cirrhosis; Lubiprostone; Neuraminidase; Non-alcoholic Fatty Liver Disease; Pregnane X Receptor; Rats; Rats, Inbred F344; Rifaximin; Tight Junction Proteins; Toll-Like Receptor 4

2022
chemdatabank.com